TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 0.300nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 0.300nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 0.400nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 0.400nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 0.600nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 1nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 1nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 1.10nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 1.10nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 1.10nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 1.20nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 1.20nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 1.20nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 1.5nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 1.5nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 1.5nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 2nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 2.20nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 2.30nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 2.40nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 2.5nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 2.70nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 3nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 3.20nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 3.30nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 3.70nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 3.80nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 3.80nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 4.10nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 4.30nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 4.30nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 4.70nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 4.90nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 5.60nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 5.80nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 6.60nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 6.80nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 6.80nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 6.90nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 7nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 7nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 7.20nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 7.90nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 8.80nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 9.30nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 110nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 190nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 190nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 270nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 280nMAssay Description:When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences,...More data for this Ligand-Target Pair